#tak-385

[amcrasto]

Relugolix (TAK-385) in phase 2 By Takeda for the treatment of endometriosis and uterine fibroids

Relugolix (TAK-385) in phase 2 By Takeda for the treatment of endometriosis and uterine fibroids

Relugolix (TAK-385)

1-[4-[1-(2,6-Difluorobenzyl)-5-(dimethylaminomethyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea

N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N’-methoxyurea

CAS NO 737789-87-6

C29-H27-F2-N7-O5-S

623.6383

Synonyms

View On WordPress

[amcrasto]

relugolix (TAK-385)

Relugolix (TAK-385)

737789-87-6  cas no

C29-H27-F2-N7-O5-S

623.6383

Synonyms

N-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N’-methoxyurea

TAK-385

UNII-P76B05O5V6

Systematic Name

Urea,…

View On WordPress